Deutsche Bank AG bought a new position in shares of CME Group Inc. (NASDAQ:CME – Free Report) during the 2nd quarter, HoldingsChannel reports. The firm bought 1,494,948 shares of the financial services provider’s stock, valued at approximately $330,129,000.
Other institutional investors also recently bought and sold shares of the company. Whipplewood Advisors LLC grew its holdings in shares of CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after buying an additional 83 shares during the last quarter. Asset Dedication LLC grew its holdings in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 37 shares during the period. Elkhorn Partners Limited Partnership acquired a new stake in shares of CME Group during the 4th quarter worth approximately $27,000. Hilton Head Capital Partners LLC acquired a new stake in CME Group during the fourth quarter valued at $28,000. Finally, Legacy Wealth Managment LLC ID increased its stake in shares of CME Group by 191.9% in the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 71 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at CME Group
In other CME Group news, Director William R. Shepard purchased 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The stock was purchased at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.30% of the stock is owned by insiders.
CME Group Trading Down 0.7%
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter last year, the company earned $2.96 earnings per share. The firm’s revenue for the quarter was up .8% on a year-over-year basis. As a group, equities research analysts expect that CME Group Inc. will post 12.27 EPS for the current fiscal year.
CME Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s payout ratio is 44.11%.
Analyst Ratings Changes
Several brokerages recently commented on CME. TD Cowen cut their price target on shares of CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Deutsche Bank Aktiengesellschaft cut their price target on CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. Barclays decreased their target price on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a report on Thursday, July 9th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and lifted their target price for the company from $316.00 to $323.00 in a report on Thursday, June 11th. Finally, Bank of America raised their target price on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a report on Thursday, July 23rd. Ten investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus price target of $291.81.
Get Our Latest Stock Analysis on CME
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
- Five stocks we like better than CME Group
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
